<DOC>
	<DOCNO>NCT03032055</DOCNO>
	<brief_summary>Vaso-Occlusive Crisis ( VOC ) , common manifestation sickle cell disease ( SCD ) , first cause death , particularly complicate acute chest syndrome ( ACS ) . The PRESEV score could help physicians good manage VOC could use future therapeutic trial . This predictive score secondary ACS validate multicenter international study .</brief_summary>
	<brief_title>Validation Predictive Score Acute Chest Syndrome</brief_title>
	<detailed_description>International multicentre prospective observational study . Prediction ACS within 15 day admission PRESEV2 score arrival . Validation Predictive Score Acute Chest Syndrome ( Presev2 ) associate categorical pain score spine /or pelvis 3 biological parameter : Reticulocytes , Leucocytes Hemoglobin . ACS define crepitant bronchial breathe association new radiologic infiltrate chest pain Inclusion criterion : - Children ( &gt; 2 year ) adults - Male Female - Homozygous SCD patient - The patient include - VOC admit emergency unit ( severe VOC define pain tenderness affect least one part body ( e.g . limb , rib , sternum , head ( skull ) , spine and/or pelvis ) require hospitalization opioids ( level 3 ) , attributable cause . - Patient health care insurance ( Europe ) - Written consent give inform purpose , progress potential risk Exclusion criterion : - No inaugural Acute Chest Syndrome - Homeless patient - Deprived liberty court administrative order guardianship - Unable understand purpose condition carry study , unable give consent STUDY SCHEDULE Screening inclusion patient admitted accident emergency department medical day unit . Inclusion visit ( day 1 ) Once admit accident emergency department , patient inform protocol ask participate study . Informed consent obtain accord local regulation sign informed consent form . The inclusion non-inclusion criterion verify . Demographic data , current previous treatment take within one month , medical history record . The following parameter score collect : Reticulocytes and/or leucocytes count , urea ( mmol/L ) Categorical pain score . The Score adjust Hydroxyurea treatment ( Yes/No ) Hb level ( g/dL ) . Plasmodium falciparum test perform Africa . Hemoculture fever ( &gt; 38Â°C ) record within 2 first day admission . Temperature , Blood pressure , Oxygen saturation , Respiratory rate , Visual analogue score record . STUDY DURATION Inclusion period : 2 year Per patient : 15 day Total duration study : 2 year</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Chest Syndrome</mesh_term>
	<criteria>Inclusion criterion : Children ( &gt; 2 year ) adults Male Female Homozygous SCD patient VOC admit emergency unit ( severe VOC define pain tenderness affect least one part body ( e.g . limb , rib , sternum , head ( skull ) , spine and/or pelvis ) require hospitalization opioids ( level 3 ) , attributable cause . Patient health care insurance ( Europe ) Written consent give inform purpose , progress potential risk Exclusion criterion : No inaugural Acute Chest Syndrome Homeless patient Deprived liberty court administrative order guardianship Unable understand purpose condition carry study , unable give consent</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>sickle cell desease</keyword>
	<keyword>vaso occlusive crisis</keyword>
	<keyword>acute chest syndrome</keyword>
	<keyword>Validation predictif score acute chest syndrome</keyword>
</DOC>